Gilpin Wealth Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
SC
PCA
MSV
BTCPP
VFA
CAM
EB
AIM
FFA
QPBE
Gilpin Wealth Management's LLY Position: Q3 2026 in Review
Gilpin Wealth Management increased its Eli Lilly (LLY) stake by 83% in Q3 2026, buying an estimated $50.7K and bringing the position to 95 shares worth $110K. The position accounts for 0.07% of the portfolio, ranked #184.
Gilpin Wealth Management first reported a position in LLY in Q4 2025 and has held it in 4 quarters since. 255 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Gilpin Wealth Management held 95 shares of Eli Lilly worth $110K as of Q3 2026.
- Gilpin Wealth Management bought 43 Eli Lilly shares in Q3 2026, an estimated $50.7K.
- Eli Lilly made up 0.07% of Gilpin Wealth Management's portfolio in Q3 2026, its #184 holding.
- Gilpin Wealth Management first reported a position in Eli Lilly in Q4 2025 and has held it in 4 quarters since.
- 255 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Gilpin Wealth Management's 13F filing for Q3 2026, filed 9 Oct 2026.